1. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Munoz-Price;Lancet Infect Dis,2013
2. European Centre for Disease Prevention and Control. Rapid risk assessment: carbapenem-resistant Enterobacteriaceae – 8 April 2016. Stockholm: ECDC; 2016. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/carbapenem-resistant-enterobacteriaceae-risk-assessment-april-2016.pdf/. [Accessed 1 March 2018].
3. European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017. https://ecdc.europa.eu/sites/portal/files/documents/AMR%202016_Final-with-cover-for-web-2017.pdf/. [Accessed 1 March 2018].
4. Sabbatucci M, Iacchini S, Iannazzo S, Farfusola C, Marella AM, Bizzotti V, et al. Sorveglianza nazionale delle batteriemie da enterobatteri produttori di carbapenemasi. Rapporto 2013–2016. Rapporti ISTISAN 2017, Istituto Superiore di Sanità; 2017. http://www.iss.it/. [Accessed 1 March 2018].
5. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015;Albiger;Euro Surveill,2015